Generic Name: ibrutinib

Pill with imprint ibr 140 mg is White, Capsule-shape and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics Inc.

Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma; Waldenström Macroglobulinemia; Lymphoma; Mantle Cell Lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).